Home › Leukemia › Virginia › Charlottesville
Leukemia clinical trials in Charlottesville, VA
5 studies for Leukemia are looking for participants at sites in and around Charlottesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- University of Virginia School of Medicine, Charlottesville
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RecruitingPhase 3
- University of Virginia Health, Charlottesville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- University of Virginia Comprehensive Cancer Center, Charlottesville
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RecruitingPhase 1/2
- Dren Investigational Site, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Charlottesville
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX31 studies
- Boston, MA27 studies
- New York City, NY21 studies
- Chicago, IL19 studies
- Los Angeles, CA17 studies
- Durham, NC14 studies
- Baldwin Park, CA14 studies
- Nashville, TN13 studies
- Columbus, OH13 studies
- Philadelphia, PA13 studies
- Atlanta, GA12 studies
- Milwaukee, WI12 studies
Other studies in Charlottesville
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia16 studies
- Prostate Cancer15 studies
- Endometrial Cancer15 studies
- Cancer (all types)14 studies
- Lung Cancer13 studies
- Metastatic Cancer12 studies
- Heart Failure11 studies
- Colorectal Cancer10 studies
- Pancreatic Cancer10 studies
- Ovarian Cancer9 studies
- Ischemic Stroke9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.